Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$1.6 million.

  • Angiodynamics' Cash from Investing Activities rose 1733.81% to -$1.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$9.0 million, marking a year-over-year decrease of 13957.36%. This contributed to the annual value of -$10.2 million for FY2025, which is 10822.68% down from last year.
  • As of Q4 2025, Angiodynamics' Cash from Investing Activities stood at -$1.6 million, which was up 1733.81% from -$1.6 million recorded in Q3 2025.
  • In the past 5 years, Angiodynamics' Cash from Investing Activities registered a high of $98.4 million during Q3 2023, and its lowest value of -$9.1 million during Q2 2021.
  • In the last 5 years, Angiodynamics' Cash from Investing Activities had a median value of -$2.4 million in 2024 and averaged $3.5 million.
  • Per our database at Business Quant, Angiodynamics' Cash from Investing Activities crashed by 51825.56% in 2021 and then soared by 285285.23% in 2023.
  • Angiodynamics' Cash from Investing Activities (Quarter) stood at -$3.8 million in 2021, then soared by 35.15% to -$2.5 million in 2022, then rose by 28.17% to -$1.8 million in 2023, then dropped by 9.37% to -$2.0 million in 2024, then increased by 17.34% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q4 2025, -$1.6 million for Q3 2025, and -$2.6 million during Q2 2025.